Physician profile
Renee Woo
NPI 1598210510
$14,269.74
in general payments reported to CMS, 2019-2025
26 companies · $4,512 in 2025
The $4,512 reported for 2025 was more than what 93% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $68.35 · 2021: $1,694 · 2022: $3,085 · 2023: $3,374 · 2024: $1,536 · 2025: $4,512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,956 · Food and Beverage: $4,467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,955.63 |
| Food and Beverage | $4,466.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evolution Surgical, INC | $5,499.72 | 2021-2025 | |
| Arthrex, INC. | $1,675.26 | 2023-2024 | |
| Treace Medical Concepts, INC. | $1,576.48 | 2022-2025 | |
| Medical Device Business Services, INC. | $1,248.26 | 2025 | Motoband |
| Smith+Nephew, INC. | $858.14 | 2022-2025 | Collagenase Santyl, Stravix, Grafix Pl |
| Organogenesis INC. | $467.70 | 2020-2023 | Puraply |
| Depuy Synthes Sales INC. | $451.03 | 2024-2025 | Motoband, Minibunion |
| Amgen INC. | $313.46 | 2024-2025 | Krystexxa |
| Stryker Corporation | $311.73 | 2025 | Ortholoc 2 Lapifuse, Augment Injectable, N/A |
| Bioventus LLC | $306.29 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Orthofix Medical, INC. | $248.38 | 2022-2025 | Physio-Stim, Accelstim |
| Kerecis Limited | $209.08 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Medtronic, INC. | $156.04 | 2025 | Venaseal |
| Crossroads Extremity Systems, LLC | $151.99 | 2021 | |
| Zimmer Biomet Holdings, INC. | $142.20 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $141.97 | 2021-2023 | |
| Mimedx Group, INC. | $113.74 | 2024-2025 | |
| Bone Support INC. | $111.24 | 2024 | Ceramentbone Void Filler, Cerament G |
| Integra Lifesciences Corporation | $80.57 | 2020-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Medela LLC | $74.86 | 2020-2022 | |
| Paragon 28, INC. | $32.46 | 2025 | Portfolio |
| Access Pro Medical, LLC | $27.05 | 2025 | Matriderm |
| Paratek Pharmaceuticals, INC. | $22.65 | 2025 | Nuzyra |
| Nevro Corp. | $17.42 | 2022 | |
| Urgo Medical North America, LLC | $16.87 | 2025 | Urgok2 |
| Boston Scientific Corporation | $15.15 | 2025 | Accolade Sr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renee Woo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.